GlaxoSmithKline enters into further Agreement with OBJ
OBJ Limited (ASX: OBJ) is pleased to announce the signing of an Evaluation Agreement
with GlaxoSmithKline Consumer Healthcare (GSK). GSK has granted permission to the
Company to release the following statement:
?gOBJ Limited wishes to advise that it has entered into a short term evaluation
agreement with GlaxoSmithKline Consumer Healthcare (GSK).
The Evaluation Agreement involves an evaluation of OBJ?fs ETP technology in a
non?]prescription consumer healthcare application.
OBJ and GSK have worked together on three previous occasions and the current
Agreement is a continuation of that relationship.?h
Background
GlaxoSmithKline is the world's second largest pharmaceutical and consumer healthcare
company with products ranging from vaccines and oncology products through to overthe?]
counter medicines and nutritional products.
OBJ first collaborated with GSK in 2006 in an advanced delivery program employing the
Company?fs Dermaportation technology. This program was further expanded to involve
both the Company?fs Dermaportation and ETP technologies. This relationship was
announced to shareholders in May 2007 following approval of that release by GSK. A
further confidential collaboration with GSK was undertaken in 2008 in an undisclosed
consumer healthcare field and the current announcement continues the work in that
same commercial field.
The results, application field and drug used in the current program are, by agreement,
to remain confidential.
- Forums
- ASX - By Stock
- WFL
- glaxosmithkline enters into further agreement
glaxosmithkline enters into further agreement
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online